Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.77M | $212.0M | 8.03% | -155.3K | 2026-06-30 |
| Vestal Point Capital, LP | 8.05M | $195.0M | 7.37% | +1.55M | 2026-06-30 |
| Deep Track Capital, LP | 7.74M | $187.0M | 7.08% | +1.39M | 2026-06-30 |
| Rubric Capital Management LP | 7.23M | $175.0M | 6.62% | +4.75M | 2026-06-30 |
| FMR LLC | 5.49M | $133.0M | 5.02% | -56.1K | 2026-06-30 |
| Price T Rowe Associates Inc | 5.44M | $131.0M | 4.98% | +2.15M | 2026-06-30 |
| Morgan Stanley | 4.76M | $115.0M | 4.36% | -169.5K | 2026-06-30 |
| State Street Corp | 4.68M | $113.0M | 4.28% | -464.0K | 2026-06-30 |
| Baker Bros. Advisors LP | 4.66M | $113.0M | 4.27% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.50M | $109.0M | 4.12% | +68.4K | 2026-06-30 |
